5-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride, 97%, 250mg

(3S,8aS)-3-Isobutylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione, 95.0%, 1g

Diethyl pyridine-2,3-dicarboxylate, 97%, 100g

3-Bromo-4-chloro-5-fluorobenzonitrile, 95.0%, 5g

2,4-Dichloro-5-[[(2-methylpropyl)amino]sulfonyl]benzoic acid, 250mg

tert-butyl 4-[(2E)-3-(dimethylamino)prop-2-enoyl]piperidine-1-carboxylate, 5g

3,5-Dibromo-2-chloro-6-(trifluoromethyl)pyridine, 250mg

METHYL 3-CHLORO-5-FLUOROPYRIDINE-2-CARBOXYLATE, 95.0%, 1g

Ethyl 5-tert-butylisoxazole-3-carboxylate, 95.0%, 250mg

n-pentano, mínimo 99 %, para síntesis, 2,5 l, envase de vidrio

4-(3,4-Methylenedioxyphenyl)-3-thiosemicarbazide, 2g

9-Oxo-9H-fluorene-2-carboxylic acid, 97.0%, 10g

trans-1,4-Dichlorocyclohexane>99.0%(GC)5g